SMLR

Insider Trades

Name	Value	Action	Price	Current Price
Murphy-Chutorian DouglasDirector, Officer: CEO, Interim CFO And Director $1.2M57.7k shares SellNov 17, 2025 $20.09 --
Murphy-Chutorian DouglasDirector, Officer: CEO, Interim CFO And Director $264k12.7k shares SellNov 17, 2025 $20.73 --
Murphy-Chutorian DouglasDirector, Officer: Chief Executive Officer $874k28.6k shares SellAug 25, 2025 $30.54 --
Murphy-Chutorian DouglasDirector, Officer: CEO $583k9.3k shares SellDec 11, 2024 $62.97 --
Murphy-Chutorian DouglasDirector, Officer: CEO $362k5.8k shares SellDec 11, 2024 $62.28 --
Murphy-Chutorian DouglasDirector, Officer: CEO $155k2.5k shares SellDec 11, 2024 $62.35 --

Trade SMLR

About Semler Scientific, Inc.

Semler Scientific, Inc. develops and delivers cutting-edge technology solutions aimed at boosting the clinical effectiveness and operational efficiency of medical professionals throughout the United States. A flagship offering from the company is QuantaFlo, a rapid, four-minute diagnostic test performed in-office to assess blood flow. This tool allows healthcare providers to incorporate crucial blood flow measurements into their comprehensive evaluations of a patient's vascular health. Their clientele is diverse, spanning various medical specialties such as cardiology, internal medicine, nephrology, endocrinology, podiatry, and family practice. Beyond individual practitioners, Semler Scientific also serves significant healthcare organizations, including insurance plans, integrated care delivery networks, independent physician groups, and other entities that engage with the healthcare sector, such as risk assessment firms. The company distributes its products via a combination of its own sales team and a network of authorized distributors. Founded in 2007, Semler Scientific, Inc. is based in Santa Clara, California.

CEO: Douglas Murphy-Chutorian
IPO Date: Feb 21, 2014

Market Data

Open: $20.33
High: $20.33
Low: $20.33
Volume: 1.6M
Avg Volume: 647.9K
52W High: $65.98
52W Low: $14.89

Valuation

Market Cap: $311M
Enterprise Value: $417M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-165M
Revenue: $56M
Net Income: $41M
Cash: $8.8M
Debt: $70k

Events

EarningsFeb 17

EPS est. -0.54 · actual 3.41